FDA BSE Rule Permits Tallow With .15% Hexane-Insoluble Impurities
This article was originally published in The Tan Sheet
Executive Summary
FDA's 1interim final rule prohibiting certain bovine risk materials in foods, dietary supplements and cosmetics to minimize exposure to bovine spongiform encephalopathy (BSE) is effective immediately
You may also be interested in...
HHS “Unified Agenda” Shows FDA Lagging On OTC Actions
FDA will publish a final rule on dietary supplement good manufacturing practices in November, according to HHS' semi-annual "unified agenda" published in the Federal Register June 28
BSE Interim Final Rules To Ban Materials In Certain Supplements
FDA and HHS will publish two interim final rules intended to ban certain bovine-derived materials from food products, including dietary supplements, in order to prevent the spread of bovine spongiform encephalopathy (BSE, also known as "mad cow disease")
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC